Advertisement

Etiologic and Pathogenetic Aspects of Systemic Lupus Erythematosus: A Critical Approach

  • W. Graninger
  • C. C. Zielinski
  • J. S. Smolen

Abstract

It is the fate of review articles and books that their conclusions run the risk of being outdated within a short period after (and sometimes even at the time of) their publication. They do, however, have the advantage that one can dare to raise slightly more critical, speculative, and philosophical views than would be advisable in an original, data-describing scientific paper. Thus, in the following pages, rather than review old and new data on the etiology and pathogenesis of human SLE, it will be our aim to point out the very few highlights of human lupus research, to discuss its conflicting matters, and to speculate on how we might be able to understand the disease better in the future.

Keywords

Systemic Lupus Erythematosus Systemic Lupus Erythe Temic Lupus Erythematosus Cell Hyperactivity Autologous Mixed Lymphocyte Reaction 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Mellors RC, Ortega LG, Holman HR (1957) Role of gamma-globulins in the pathogenesis of renal lesions in systemic lupus erythematosus and chronic membraneous glomerulonephritis, with an observation on lupus erythematosus cell reaction. J Exp Med 106: 191–203PubMedCrossRefGoogle Scholar
  2. 2.
    Paronetto F, Koffler D (1965) Immunofluorescent localization of immunoglobulins, complement and fibrinogen in human diseases: I. Systemic lupus erythematosus. J Clin Invest 44: 1657–1664PubMedCrossRefGoogle Scholar
  3. 3.
    Lewis EJ, Busch GJ, Schur PH (1970) Gamma G globulin subgroup composition of the glomerular deposits in renal diseases. J Clin Invest 49: 1103–1113PubMedCrossRefGoogle Scholar
  4. 4.
    Krishnan C, Kaplan MH (1967) Immunopathologic studies of systemic lupus erythematosus: II. Antinuclear reaction of gamma-globulin eluted from homogenates and isolated glomeruli of kidneys from patients with lupus nephritis. J Clin Invest 46: 569–579PubMedCrossRefGoogle Scholar
  5. 5.
    Andres GA, Accinni L, Beiser SMN, Christian CL, Cinotti GA, Erlanger BF, Hsu KC, Segal BC (1970) Localization of fluorescein labelled antinucleotide antibodies in glomeruli of patients with active systemic lupus erythematosus and nephritis. J Clin Invest 49: 2106–2118PubMedCrossRefGoogle Scholar
  6. 6.
    Koffler D, Agnello V, Kunkel HG (1974) Polynucleotide immune complexes in serum and glomeruli of patients with systemic lupus erythematosus. Am J Pathol 74: 109–122PubMedGoogle Scholar
  7. 7.
    Maddison PJ, Reichlin M (1979) Deposition of antibodies to a soluble cytoplasmic antigen in the kidneys of patients with systemic lupus erythematosus. Arthritis Rheum 22: 858–863PubMedCrossRefGoogle Scholar
  8. 8.
    Yoshiki T, Mellors RC, Strand M, August JT (1974) The viral envelope glycoprotein of murine leukemia virus and the pathogenesis of immune-complex glomerulonephritis of New Zealand mice. J Exp Med 140: 1011–1027PubMedCrossRefGoogle Scholar
  9. 9.
    Agnello V, Koffler D, Eisenberg JW, Winchester RJ, Kunkel HG (1971) Clq precipitins in the sera of patients with systemic lupus erythematosus and other hypocomplementemic states: characterization of high and low molecular weight types. J Exp Med 134: 228s - 241sPubMedGoogle Scholar
  10. 10.
    Lambert PH et al (1978) A WHO collaborative study of the evaluation of eighteen methods for detecting immune complexes in serum. J Clin Lab Immunol 1: 1–16Google Scholar
  11. 11.
    Menzel EJ, Smolen JS, Knapp W, Scherak O, Steffen C (1979) Klinische Relevanz zirkulierender Immunkomplexe bei Patienten mit systemischem Lupus erythematodes and chronischer Polyarthritis. Acta Med Austriaca 6: 212–214PubMedGoogle Scholar
  12. 12.
    Bruneau C, Benveniste J (1979) Circulating DNA: anti-DNA complexes in systemic lupus erythematosus. J Clin Invest 64: 191–198PubMedCrossRefGoogle Scholar
  13. 13.
    Schur PH, Sandson J (1968) Immunologic factors and clinical activity in systemic lupus erythematosus. N Engl J Med 278: 533–538PubMedCrossRefGoogle Scholar
  14. 14.
    Johnson KJ, Ward PA (1982) Biology of disease: newer concepts in the pathogenesis of immune-complex-induced tissue injury. Lab Invest 17: 218–226Google Scholar
  15. 15.
    Koffler D, Agnello V, Kunkel HG (1974) Polynucleotide inmune complexes in serum and glomeruli of patients with systemic lupus erythematosus. Am J Pathol 74: 109–124PubMedGoogle Scholar
  16. 16.
    Barnett EV (1979) Circulating immune conplexes: their immunochemistry, detection and importance. Ann Intern Med 91: 430–440Google Scholar
  17. 17.
    Leon SA, Green A, Ehrlich GC, Poland M, Shapiro B (1977) Avidity of antibodies in SLE: relationship of severity of renal involvement. Arthritis Rheum 20: 23–29PubMedCrossRefGoogle Scholar
  18. 18.
    Gershwin ME, Steinberg AD (1975) Qualitative characteristics of anti-DNA antibodies in lupus nephritis. Arthritis Rheum 17: 947–954CrossRefGoogle Scholar
  19. 19.
    Clough JD, Valenzuela R (1980) Relationship of renal histopathology in SLE nephritis to immunoglobulin class of anti-DNA. Am J Med 68: 80–85PubMedCrossRefGoogle Scholar
  20. 20.
    Winfield JB, Faiferman I, Koffler D ( 1977 Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus: association of high avidity anti-native DNA antibody with glomerulonephritis. J Clin Invest 59: 90–96PubMedCrossRefGoogle Scholar
  21. 21.
    Cochrane CG, Hawkins DJ (1968) Studies on circulating immune complexes: III. Factors governing the circulating complexes to localize in blood vessels. J Exp Med 127: 137–146PubMedCrossRefGoogle Scholar
  22. 22.
    Soothill JF, Steward MW (1971) The immunopathologic significance of the heterogeneity of antibody affinity. Clin Exp Immunol 9: 193–202PubMedGoogle Scholar
  23. 23.
    Eblin F, Hahn BH (1980) Restricted subpopulations of DNA antibodies in kidneys of mice with systemic lupus: comparison of antibodies in serum and renal eluates. Arthritis Rheum 23: 392–403CrossRefGoogle Scholar
  24. 24.
    Izui S, Lambert PH, Miescher PA (1976) In vitro demonstration of a particular affinity of glomerular basement membrane and collagen for DNA: a possible basis for a local formation of DNA-anti-DNA complexes in systemic lupus erythematosus. J Exp Med 144: 428–436PubMedCrossRefGoogle Scholar
  25. 25.
    Izui S, Lambert PH, Fournie GJ, Turler H, Miescher PA (1977) Features of systemic lupus erythematosus in mice injected with bacterial lipopolysaccharides: identification of circulating DNA and renal localization of DNA-anti-DNA complexes. J Exp Med 145: 1115–1130PubMedCrossRefGoogle Scholar
  26. 26a.
    Gelfand MC, Frank MM, Green I (1975) A receptor for the third component of complement in the human renal glomerulus. J Exp Med 142: 1029–1034PubMedCrossRefGoogle Scholar
  27. 26b.
    Kazatchkine MD, Fearon DT, Appay MD, Mandet C, Bariety J (1982) Immunohistochemical study of the human glomerular C3b receptor in normal kidney and in seventy-five cases of renal diseases. J Clin Invest 69: 900–912PubMedCrossRefGoogle Scholar
  28. 27.
    Finbloom DS, Plotz PH (1977) Studies of reticuloendothelial function in the mouse with model immune complexes: II. Serum clearance, tissue uptake and reticuloendothelial saturation in NZB/W mice. J Immunol 123: 1600–1603Google Scholar
  29. 28.
    Siegel I, Liu TL, Gleicher N (1981) The red cell immune system. Lancet 2: 556–558PubMedCrossRefGoogle Scholar
  30. 29.
    Frank MM, Hamburger MI, Lawley TJ, Kimberly RP, Plotz PH (1979) Defective reticuloendothelial system Fc receptor function in systemic lupus erythemaosus. N Engl J Med 300: 518–523PubMedCrossRefGoogle Scholar
  31. 30.
    Iida K, Mornaghi R, Nussenzweig V (1982) Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus. J Exp Med 155: 1427–1438PubMedCrossRefGoogle Scholar
  32. 31.
    Dixon FJ, Feldman JD, Vazquez JJ (1961) Experimental glomerulonephritis: the pathogenesis of a laboratory model resembling the spectrum of glomerulonephritis. J Exp Med 113: 899–920PubMedCrossRefGoogle Scholar
  33. 32.
    Kappler JW, Marrack P (1978) The role of H-2 linked genes in helper T cell function: IV. Importance of T-cell genotype and host environment in I-region and Ir gene expression. J Exp Med 148: 1510–1522PubMedCrossRefGoogle Scholar
  34. 33.
    Singer A, Hathcock KS, Hodes RJ (1979) Cellular and genetic control of antibody responses: V. Helper T-cell recognition of H-2 determinants on accessory but not B cells. J Exp Med 149: 1208–1226PubMedCrossRefGoogle Scholar
  35. 34.
    Soothill JF, Steward MW (1971) The immunopathological significance of the heterogeneity of antibody affinity. Clin Exp Immunol 9: 193–202PubMedGoogle Scholar
  36. 35.
    Germain RN, Benacerraf B (1981) A single major pathway of T-lymphocyte interactions in antigen-specific immune suppression. Scand J Immunol 13: 1–10PubMedCrossRefGoogle Scholar
  37. 36.
    Lawley TJ, Hall RP, Fauci AS, Katz SI, Hamburger MI, Frank MM (1981) Defective Fc receptor functions associated with the HLA B8 DR3 haplotype. N Engl J Med 304: 185–192PubMedCrossRefGoogle Scholar
  38. 37.
    Williams BD, O’Sullivan MM, Ratanachaiyavong S (1985) Reticuloendothelial Fc function in normal individuals and its relationship to the HLA antigen DR3. Clin exp Immunol 60: 532–538PubMedGoogle Scholar
  39. 38.
    Miyakawa Y, Yamada A, Kosaka K, Tsuda F, Kosugi E, Mayumi M (1981) Defective immune adherence ( C3b) receptors on erythrocytes from patients with systemic lupus erythematosus. Lancet 2: 493PubMedCrossRefGoogle Scholar
  40. 39.
    Wilson JG, Wong WW, Schur PH, Fearon DT (1982) Mode of inheritance of decreased C3b receptors on erythrocytes of patients with systemic lupus erythematosus. N Engl J Med 307: 981PubMedCrossRefGoogle Scholar
  41. 40.
    Wilson JG, Fearon DT (1984) Altered expression of complement receptors as a pathogenetic factor in systemic lupus erythematosus. Arthritis Rheum 27: 1321–1328PubMedCrossRefGoogle Scholar
  42. 41.
    Walport MJ, Ross DG, Mackworth-Young C, Watson JV, Hogg N, Lachmann PJ (1985) Family studies of erythrocyte complement receptor type 1 levels: reduced levels in patients with SLE are acquired, not inherited. Clin Exp Immunol 59: 547–554PubMedGoogle Scholar
  43. 42.
    Steinberg AD, Smolen JS, Sakane T, Kumagai S, Morimoto C, Chused TM, Green I, Hirata F, Siminovitch KA, Steinberg RT (1982) Immune regulatory abnormalities in systemic lupus erythematosus. In: Cummings, Michael, Wilson, (eds) Immune mechanisms in renal disease. Plenum, New York, pp 529–548Google Scholar
  44. 43.
    Rekvig OP, Hannestad K (1979) Certain polyclonal antinuclear antibodies crossreact with the surface membrane of human lymphocytes and granulocytes. Scand J Immunol 6: 1042–1049Google Scholar
  45. 44.
    Searles RP, Messner RP, Bankhurst AD (1979) Cross reactivity of antilymphocyte and antinuclear antibodies in systemic lupus erythematosus. Clin Immunol Immunopathol 14: 292–299PubMedCrossRefGoogle Scholar
  46. 45.
    Hannestad K, Stollar BD (1978) Certain rheumatoid factors react with nucleosomes. Nature 275: 671–673PubMedCrossRefGoogle Scholar
  47. 46.
    Rekvig OP, Hannestad K (1980) Human autoantibodies that react with both cell nuclei and plasma membranes display specificity for the octamer of histones H2A, H2B, H3, and H4 in high salt. J Exp Med 152: 1720–1733PubMedCrossRefGoogle Scholar
  48. 47.
    Kofler R, Perlmutter RM, Noonan DJ, Dixon FJ, Theofilopoulos AN (1985) Ig heavy chain variable region gene complex of lupus mice exhibits normal restriction fragment length polymorphism. J Exp Med 162: 346–351PubMedCrossRefGoogle Scholar
  49. 48.
    Halpern R, Schiffenbauer J, Solomon G, Diamond B (1984) Detection of masked anti-DNA antibodies in lupus sera by a monoclonal anti-idiotype. J Immunol 133: 1852–1856PubMedGoogle Scholar
  50. 49.
    Isenberg DA, Shoenfeld Y, Madaio MP, Rauch J, Reichlin M, Stollar BD, Schwartz RS (1984) Anti-DNA antibody idiotypes in systemic lupus erythematosus. Lancet 2: 417–422PubMedCrossRefGoogle Scholar
  51. 50.
    Jacob L, Lety MA, Louvard D, Bach JF (1985) Binding of a monoclonal anti-DNA autoantibody to identical protein(s) present at the surface of several human cell types involved in lupus pathogenesis. J Clin Invest 75: 315–317PubMedCrossRefGoogle Scholar
  52. 51.
    Koopman WJ, Schrohenloher RE (1980) In vitro synthesis of IgM rheumatoid factor by lymphocytes from healthy adults. J Immunol 125: 934–939PubMedGoogle Scholar
  53. 52.
    Cairns E, Block J, Bell DA (1984) Anti-DNA autoantibody producing hybridomas of normal human lymphoid cell origin. J Clin Invest 74: 880–887PubMedCrossRefGoogle Scholar
  54. 53.
    Harley JB, Kaine JL, Fox OF, Reichlin M, Gruber B (1985) Ro/SSA antibody and antigen in congenital complete heart block. Arthritis Rheum 28: 1321–1325PubMedCrossRefGoogle Scholar
  55. 54.
    Maddison PJ, Skinner RP, Vlachoyiannopoulos P, Brennand DM, Hough D (1985) Antibodies to nRNP, Sm, Ro (SSA) and La (SSB) detected by ELISA: their specificity and inter-relations in connective tissue disease. Clin Exp Immunol 62: 337–345PubMedGoogle Scholar
  56. 55.
    Seelig HP (1983) Antikörper gegen Zellkernantigene. Fischer, Stuttgart, pp 43 and 60Google Scholar
  57. 56.
    Swaak T, Smeenk R (1985) Detection of anti-dsDNA as a diagnostic tool: a prospective study in 441 non-systemic lupus erythematosus patients with anti-dsDNA antibody (antidsDNA). Ann Rheum Dis 44: 245–251PubMedCrossRefGoogle Scholar
  58. 57.
    Yoshida H, Yoshida M, Izui S, Lambert PH (1985) Distinct clonotypes of anti-DNA antibodies in mice with lupus nephritis. J Clin Invest 76: 685–694PubMedCrossRefGoogle Scholar
  59. 58.
    Sano H, Morimoto C (1982) DNA isolated from DNA/anti-DNA antibody immune complexes in systemic lupus erythematosus is rich in guanine-cytosine content. J Immunol 128: 1341–1345PubMedGoogle Scholar
  60. 59.
    Steinman CR (1984) Circulating DNA in systemic lupus erythematosus: isolation and characterization. J Clin Invest 73: 832–841PubMedCrossRefGoogle Scholar
  61. 60a.
    Seelig HP (1983) Antikörper gegen Zellkernantigene. Fischer, Stuttgart, pp 8–11Google Scholar
  62. 60b.
    Schwartz RS, Stollar BD (1985) Origins of anti-DNA autoantibodies. J Clin Invest 75: 321–327PubMedCrossRefGoogle Scholar
  63. 61.
    Diamond B, Scharff MD (1984) Somatic mutation of the T15 heavy chain gives rise to an antibody with autoantibody specificity. Proc Natl Acad Sci USA 81: 5841–5844PubMedCrossRefGoogle Scholar
  64. 62a.
    Datta SK, Stollar BD, Schwartz RS (1983) Normal mice express idiotypes related to autoantibody idiotypes of lupus mice. Proc Natl Acad Sci USA 80: 2723–2727PubMedCrossRefGoogle Scholar
  65. 62b.
    Halpern R, Davidson A, Lazo A, Solomon G, Lahita R, Diamond B (1985) Familial systemic lupus erythematosus: presence of a cross-reactive idiotype in healthy family members. J Clin Invest 76: 731–736PubMedCrossRefGoogle Scholar
  66. 63.
    Arnett FC, Reveille JD, Wilson RW, Provost TT, Bias WB (1984) Systemic lupus erythematosus: current state of the genetic hypothesis. Semin Arthritis Rheum 14: 24–35PubMedCrossRefGoogle Scholar
  67. 64.
    Raveche ES, Novotny EA, Hansen CT, Tjio JH, Steinberg AD (1981) Genetic studies in NZB mice: V. Recombinant inbred lines demonstrate that separate genes control autoimmune phenotype. J Exp Med 153: 1187–1197PubMedCrossRefGoogle Scholar
  68. 65.
    Taurog JD, Raveche ES, Smathers PA, Glimcher LH, Huston DP, Hansen CT, Steinberg AD (1981) T cell abnormalities in NZB mice occur independently of autoantibody production. J Exp Med 153: 221–234PubMedCrossRefGoogle Scholar
  69. 66.
    Yoshida H, Kohno A, Ohta K, Hirose S, Maruyama N, Shirai T (1981) Genetic studies of autoimmunity in New Zealand mice: III. Associations among anti-DNA antibodies, NTA, and renal disease in ( NZB x NZW) FI X NZW backcross mice. J Immunol 127: 433–337PubMedGoogle Scholar
  70. 67.
    Eastcott JW, Schwartz RS, Datta SK (1983) Genetic analysis of the inheritance of B cell hyperactivity in relation to the development of autoantibodies and glomerulonephritis in NZBxSWR crosses. J Immunol 131: 2232–2239PubMedGoogle Scholar
  71. 68.
    Cleland LG, Bell DA, Williams M, Saurino BC (1978) Familial lupus: family studies of HLA and serologic findings. Arthritis Rheum 21: 183–191PubMedCrossRefGoogle Scholar
  72. 69.
    Reinertsen JL, Klippel JH, Johnson AH, Steinberg AD, Decker JL, Mann DL (1982) Family studies of B lymphocyte alloantigens in systemic lupus erythematosus. J Rheumatol 9: 253–262Google Scholar
  73. 70.
    Reinertsen JL, Klippel JH, Johnson AH, Decker JL, Steinberg AD, Mann DL (1978) B lymphocyte alloantigens associated with systemic lupus erythematosus. N Engl J Med 299: 515–518PubMedCrossRefGoogle Scholar
  74. 71.
    Gibosky A, Winchester RJ, Patarroyo M, Kunkel HG (1978) Disease associations of the Ia-like human alloantigens: contrasting patterns in rheumatoid arthritis and systemic lupus erythematosus. J Exp Med 148: 1728–1732CrossRefGoogle Scholar
  75. 72.
    Scherak O, Smolen JS, Mayr WR (1980) HLA-DRw3 and systemic lupus erythematosus. Arthritis Rheum 23: 954–957PubMedCrossRefGoogle Scholar
  76. 73.
    Celada A, Barras C, Benzonana G, Jeannet M (1979) Increased frequency of HLA-DRw3 in systemic lupus erythematosus. N Engl J Med 301: 1398 (Letter)Google Scholar
  77. 74.
    Schur PH, Meyer I, Garovoy M, Carpenter CB (1982) Associations between systemic lupus erythematosus and the major histocompatibility complex: clinical and immunological considerations. Clin Immunol Immunopathol 24: 263–275PubMedCrossRefGoogle Scholar
  78. 75.
    Smolen JS, Klippel JH, Penner E, Reichlin M, Steinberg AD, Chused TM, Zielinski CC, Scherak O, Hartter E, Wolf A, Davie R, Mann DL, Mayr WR (1986) HLA-DR antigens in specificity of autoantibody responses to nuclear antigens (submitted for publication )Google Scholar
  79. 76.
    Ahearn JM, Provost TT, Dorsch CA, Stevens MB, Bias WB, Arnett FC (1982) Interrelationships of HLA-DR. MB and MT phenotypes, autoantibody expression, and clinical features in systemic lupus erythematosus. Arthritis Rheum 25: 1031–1040PubMedCrossRefGoogle Scholar
  80. 77.
    Porter RR (1985) The complement components coded in the major histocompatibility complexes and their biological activities. Immunol Rev 87: 7–17PubMedCrossRefGoogle Scholar
  81. 78.
    Fielder AHL, Walport MJ, Batchelor JR, Rynes RI, Black CM, Dodi IA, Hughes GRV (1983) Family studies of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility. Br Med J 286: 425–428CrossRefGoogle Scholar
  82. 79.
    Fu SM, Stern R, Kunkel HG, Dupont B, Hansen JA, Day NK, Good RA, Jersild C, Fontino M (1975) Mixed lymphocyte culture determinants and C2 deficiency: LD7a associated with C2 deficiency in four families. J Exp Med 142: 495PubMedCrossRefGoogle Scholar
  83. 80.
    Carroll MC, Belt KT, Palsdottir A, Yu Y (1985) Molecular genetics of the fourth component of human complement and steroid 21-hydroxylase. Immunol Rev 87: 39–60PubMedCrossRefGoogle Scholar
  84. 81.
    Roubinian JR, Talal N, Greenspan JS, Goodman JR, Siiteri PK (1978) Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice. J Exp Med 147: 1568–1583PubMedCrossRefGoogle Scholar
  85. 82.
    Steinberg AD, Melez KA, Raveche ES, Reeves JP, Boegel WA, Smathers PA, Taurog JD, Weinlein L, Duvic M (1979) Approach to the study of the role of sex hormones in autoimmunity. Arthritis Rheum 22: 1170–1176PubMedCrossRefGoogle Scholar
  86. 83.
    Lahita RG, Bradlow HL, Kunkel HG, Fishman J (1981) Increased 16alpha-hydroxylation of estradiol in systemic lupus erythematosus. J Clin Endocrinol Metab 53: 174–178PubMedCrossRefGoogle Scholar
  87. 84.
    Lahita RG, Bradlow HL, Fishman J, Kunkel HG (1982) Estrogen metabolism in systemic lupus erythematosus: patients and family members. Arthritis Rheum 25: 843–846PubMedCrossRefGoogle Scholar
  88. 85.
    Stern R, Fishman J, Brudman H, Kunkel HG (1977) Systemic lupus erythematosus associated with Klinefelter’s syndrome. Arthritis Rheum 20: 18–22PubMedCrossRefGoogle Scholar
  89. 86.
    Lahita RG, Chiorazzi N, Gibofsky A, Winchester RJ, Kunkel HG (1983) Familial systemic lupus erythematosus in males. Arthritis Rheum 26: 39–44PubMedCrossRefGoogle Scholar
  90. 87.
    Steinberg AD, Melez KA, Raveche ES, Reeves JP, Boegel W (1979) Approach to the study of the role of sex hormones in autoimmunity. Arthritis Rheum 22: 1170–1175PubMedCrossRefGoogle Scholar
  91. 88.
    Smolen JS, Steinberg AD (1981) Systemic lupus erythematosus and pregnancy: clinical, immunological, and theoretical aspects. In: Gleicher N (Ed) Reproductive immunology. Liss, New York pp 283–302 (Progress in biological research, vol 67 )Google Scholar
  92. 89.
    Talai N (1982) Sex hormones and modulation of immune response in SLE. Clin Rheum Dis 8: 23–28Google Scholar
  93. 90.
    Izui S, Lambert PH, Fournie PH, Turler H, Miescher PA (1977) Features of systemic lupus erythematosus in mice injected with bacterial lipopolysaccharides. J Exp Med 145: 1115–1130PubMedCrossRefGoogle Scholar
  94. 91.
    Smith HR, Green DR, Raveche ES, Smathers PK, Gershon RK, Steinberg AD (1982) Studies of the induction of anti-DNA in normal mice. J Immunol 129: 2332–2237PubMedGoogle Scholar
  95. 92.
    Jasin HE, Ziff M (1975) Immunoglobulin synthesis by peripheral blood cells in systemic lupus erythematosus. Arthritis Rheum 18: 218–228CrossRefGoogle Scholar
  96. 93.
    Budman DR, Merchant EB, Steinberg AD (1977) Increased spontaneous activity of antibody forming cells in the peripheral blood of patients with active systemic lupus erythematosus. Arthritis Rheum 20: 829–833PubMedCrossRefGoogle Scholar
  97. 94.
    Nies KM, Louie JS (1978) Impaired immunoglobulin synthesis by peripheral blood cells in systemic lupus erythematosus. Arthritis Rheum 21: 51–58PubMedCrossRefGoogle Scholar
  98. 95.
    Tsokos GC, Magrath IT, Balow JE (1983) Epstein-Barr virus induces normal B-cell responses but defective suppressor T cell responses in patients with systemic lupus erythematosus. J Immunol 131: 1797–1801PubMedGoogle Scholar
  99. 96.
    Ginsburg WW, Finkelman FD, Lipsky PE (1979) Circulating and pokeweed mitogen induced immunoglobulin-secreting cells in systemic lupus erythematosus. Clin Exp Immunol 35: 76–88PubMedGoogle Scholar
  100. 97.
    Beale MG, Nash GS, Bertovich MJ, McDermott P (1982) Similar disturbance in B cell activity and regulatory T cell function in Henoch-Schönlein purpura and systemic lupus erythematosus. J Immunol 128: 486–491PubMedGoogle Scholar
  101. 98.
    Saiki O, Saeki Y, Kishimoto S (1985) Spontaneous immunoglobulin A secretion and lack of mitogen-responsive B cells in systemic lupus erythematosus. J Clin Invest 76: 1865–1870PubMedCrossRefGoogle Scholar
  102. 99.
    Scher I, Steinberg AD, Berning AK, Paul WE (1975) X-linked B-lymphocyte immune defect in CBA/N mice: II. Studies of mechanisms underlying the immune defect. J Exp Med 142: 637–650PubMedCrossRefGoogle Scholar
  103. 100.
    Smathers PA, Steinberg BJ, Reeves JP, Steinberg AD (1982) Effect of polyclonal immune stimulators upon NZB.xid congenic mice. J Immunol 128: 1414–1419PubMedGoogle Scholar
  104. 101.
    Smith HR, Chused TM, Steinberg AD (1983) The effect of the X-linked immune deficiency gene (xid) upon the Y chromosome-related disease of BXSB mice. J Immunol 131: 1257–1260PubMedGoogle Scholar
  105. 102.
    Gershon RK (1980) Immunoregulation circa 1980. J Allergy Clin Immunol 66: 18–22PubMedCrossRefGoogle Scholar
  106. 103.
    Green DR, Flood PM, Gershon RK (1983) Immunoregulatory T cell pathways. Annual Review of Immunology 1: 439PubMedCrossRefGoogle Scholar
  107. 104.
    Dorf ME, Benacerraf B (1984) Suppressor cells and immunoregulation. Annual Review of Immunology 2: 127PubMedCrossRefGoogle Scholar
  108. 105.
    Abdou NI, Sagawa A, Pascal E, Hevert J, Sadeghee S (1976) Suppressor T cell abnormality in idiopathic systemic lupus erythematosus. Clin Immunol Immunopathol 6: 192–199PubMedCrossRefGoogle Scholar
  109. 106.
    Bresnihan B, Jasin HE (1977) Suppressor function of peripheral blood mononuclear cells in normal individuals and in patients with systemic lupus erythematosus. J Clin Invest 59: 106–116PubMedCrossRefGoogle Scholar
  110. 107.
    Sakane T, Steinberg AD, Green I (1978) Studies of immune function of patients with SLE: I. Dysfunction of suppressor T cells related to impaired generation of, rather than response to, suppressor cells. Arthritis Rheum 21: 657–664PubMedCrossRefGoogle Scholar
  111. 108.
    Tsokos GC, Balow JE (1983) Phenotypes of T lymphocytes in systemic lupus erythematosus: decreased cytotoxic/suppressor subpopulation is associated with deficient allogeneic cytotoxic responses rather than with concanavalin A-induced suppressor cells. Clin Immunol Immunopathol 26: 267–275PubMedCrossRefGoogle Scholar
  112. 109.
    Sagawa A, Abdou NI (1979) Suppressor cell antibody in systemic lupus erythematosus: possible mechanism for suppressor cell dysfunction. J Clin Invest 63: 536–539PubMedCrossRefGoogle Scholar
  113. 110.
    Sakane T, Steinberg AD, Reeves JP, Green I (1979) Studies of immune functions in systemic lupus erythematosus. Complement-dependent immunoglobulin M anti-thymus-derived cell antibodies preferentially inactivate suppressor cells. J Clin Invest 63: 954–965PubMedCrossRefGoogle Scholar
  114. 111.
    Morimoto C, Reinherz EL, Abe T, Homma M, Schlossman SF (1980) Characteristics of anti-T cell antibodies in SLE: evidence for selective reactivity with normal suppressor cells defined by monoclonal antibodies. Clin Immunol Immunopathol 16: 474–484PubMedCrossRefGoogle Scholar
  115. 112.
    Morimoto C, Reinherz EL, Schlossmann SF, Schur PH, Mills JA, Steinberg AD (1980) Alterations in immunoregulatory T cell subsets in active systemic lupus erythematosus. J Clin Invest 66: 1171–1174PubMedCrossRefGoogle Scholar
  116. 113.
    Steinberg AD, Smolen JS, Sakane T, Kumagai S, Morimoto C, Chused TM, Green I, Hirata F, Siminovitch KA, Steinberg RT (1982) Immune regulatory abnormalities in systemic lupus erythematosus. In: Cummings, Michael, Wilson (Eds) Immune mechanisms in renal disease. Lenum New York, pp 529–548Google Scholar
  117. 114.
    Delfraissy JE, Segond P, Gelanaud P, Wallon C, Massias P, Dormont J (1980) Deprived primary in vitro antibody response in untreated systemic lupus erythematosus. T helper cell defect and lack of defective suppressor cell function. J Clin Invest 66: 141–148PubMedCrossRefGoogle Scholar
  118. 115.
    Kumagai S, Sredni B, House S, Steinberg AD, Green I (1982) Defective regulation of B lymphocyte colony formation in patients with systemic lupus erythematosus. J Immunol 128: 258–262PubMedGoogle Scholar
  119. 116.
    Edelson R, Finkelman F, Steinberg AD, et al (1978) Reactivity of lupus erythematosus antibodies with leukemic helper T cells. J Invest Dermatol 70: 42–50PubMedCrossRefGoogle Scholar
  120. 117.
    Morimoto C, Reinherz EL, Distaso JA, Steinberg AD, Schlossman SF (1984) Relationship between systemic lupus erythematosus T cell subsets, anti-T cell antibodies, and T cell functions. J Clin Invest 73: 689PubMedCrossRefGoogle Scholar
  121. 118.
    Smolen JS, Chused TM, Leiserson WM, Reeves JP, Ailing D, Steinberg AD (1982) Heterogeneity of immunoregulatory T correlation with clinical features. Am J Med 72: 783–790PubMedCrossRefGoogle Scholar
  122. 119.
    Smolen JS, Morimoto Ch, Steinberg AD, Wolf A, Schlossman SF, Steinberg RT, Penner E, Reinherz E, Reichlin M, Chused TM (1985) Systemic lupus erythematosus: delineation of subpopulations by clinical, serologic, and T cell subset analysis. Am J Med Sci 289: 139–147PubMedCrossRefGoogle Scholar
  123. 120.
    Bakke AC, Kirkland PA, Kitridou RC, Horwitz DA (1983) T lymphocyte subsets in systemic lupus erythematosus. Arthritis Rheum 26: 745–750PubMedCrossRefGoogle Scholar
  124. 121.
    Taurog JD, Raveche ES, Smathers PA, Steinberg AD (1981) T cell abnormalities in NZB mice occur independently of autoantibody production. J Exp Med 153: 221–234PubMedCrossRefGoogle Scholar
  125. 122.
    Primi D, Hammarstrom L, Smith CIE (1978) Genetic control of lymphocyte suppression: I. Lack of suppression in aged NZB mice is due to B cell defect. J Immunol 121: 2241–2243PubMedGoogle Scholar
  126. 123.
    Cantor H, McVay-Boudreau L, Hugenberger J, Naidorf K, Shen FW, Gershon RK (1978) Immunoregulatory circuits among T-cell subsets: II. Physiologic role of feedback inhibition in vivo: absence in NZB mice. J Exp Med 147: 1116–1125PubMedCrossRefGoogle Scholar
  127. 124.
    Gershon RK, Horowitz M, Kemp JD, Murphy DB, Murphy ED (1978) The cellular site of immunoregulatory breakdown in the 1pr mutant mouse. In: Rose NR, Bigazzi PE, Warner NL (Eds) Genetic control of autoimmune disease. Elsevier North Holland, New York, pp 223–227Google Scholar
  128. 125.
    Sakane TA, Steinberg AD, Green I (1978) Failure of autologous mixed lymphocyte reactions between T and non-T cells in patients with systemic lupus erythematosus. Proc Natl Acad Sci USA 75: 135–142CrossRefGoogle Scholar
  129. 126.
    Kuntz MM, Innes JB, Weksler ME (1979) The cellular basis of the impaired autologous mixed lymphocyte reaction in patients with systemic lupus erythematosus. J Clin Invest 63: 151–154PubMedCrossRefGoogle Scholar
  130. 127.
    Smith JB, De Horatius RJ (1982) Deficient autologous mixed lymphocyte reaction correlates with disease activity in systemic lupus erythematosus and rheumatoid arthritis. Clin Exp Immunol 47: 155–162.Google Scholar
  131. 128.
    Smolen JS, Siminovich K, Luger TA, Steinberg AD (1983) Responder cells in the human autologous mixed lymphocyte reaction (AMLR). Characterization and interactions in healthy individuals and patients with systemic lupus erythematosus. Behring Institute Mitteilungen 72: 135–142PubMedGoogle Scholar
  132. 129.
    Smith JB, Pasternak PD (1978) Syngeneic mixed lymphocyte reaction in mice: strain distribution, kinetics, participating cells, and absence in NZB mice. J Immunol 121: 1889–1893PubMedGoogle Scholar
  133. 130.
    Glimcher LH, Steinberg AD, House SB, Green I (1980) The autologous mixed lymphocyte reaction in strains of mice with autoimmune disease. J Immunol 125: 1832–1837PubMedGoogle Scholar
  134. 131.
    Sakane T, Kotani H, Takada S, Murakawa Y, Ueda Y (1983) A defect in suppressor circuits among OKT4+ cell populations in patients independently of a defect in the OKT8 + suppressor T cell function. J Immunol 131: 753–761PubMedGoogle Scholar
  135. 132.
    Murakawa Y, Takada S, Ueda Y, Suzuki N, Hoshino T, Sakane T (1985) Characterization of T lymphocyte subpopulations responsible for deficient interleukin 2 activity in patients with systemic lupus erythematosus. J Immunol 134: 187–195PubMedGoogle Scholar
  136. 133.
    Okudaira K, Searles RP, Ceuppens JL, Williams RC (1982) Anti-Ia reactivity in sera from patients with systemic lupus erythematosus. J Clin Invest 69: 17–24PubMedCrossRefGoogle Scholar
  137. 134.
    Litvin DA, Cohen PL, Winfield JB (1983) Characterization of warm-reactive IgG anti-lymphocyte antibodies in systemic lupus erythematosus: relative specificity for mitogenactivated T cells and their soluble products. J Immunol 130: 181–186PubMedGoogle Scholar
  138. 135.
    Shirai T, Hayakawa K, Okumura KO, Tada T (1978) Differential cytotoxic effect of natural thymocytotoxic autoantibody of NZB mice on functional subsets of T cells. J Immunol 120: 1924–1929PubMedGoogle Scholar
  139. 136.
    Linker-Israeli M, Bakke AC, Quismorio FP, Horwitz D (1985) Correction of Interleukin-2 production in patients with systemic lupus erythematosus by removal of spontaneously activated suppressor cells. J Clin Invest 75: 762–768PubMedCrossRefGoogle Scholar
  140. 137.
    Yu DTY, Winchester RJ, Fu SM, Kunkel HG (1980) Peripheral blood Ia positive T cells: increases in certain diseases and after immunization. J Exp Med 151: 91–100PubMedCrossRefGoogle Scholar
  141. 138.
    James SP, Yenokida GG, Graeff AS, Elson CO, Strober W (1981) Immunoregulatory function of T cells activated in the autologous mixed lymphocyte reaction. J Immunol 127: 2605–2609PubMedGoogle Scholar
  142. 139.
    Smith JB, Knowlton RP (1979) Activation of suppressor T-cells in human autologous mixed lymphocyte culture. J Immunol 123: 419–422PubMedGoogle Scholar
  143. 140.
    Dubois EL, Tuffanelli DL (1964) Clinical manifestations of systemic lupus erythematosus: computer analysis of 520 cases. JAMA 190: 104–111PubMedGoogle Scholar
  144. 141.
    Ropes MW (1976) Systemic lupus erythematosus. Harvard University Press, CambridgeGoogle Scholar
  145. 142.
    Louis PA, Lambert PH (1979) Lipopolysaccharides: from immune stimulation to autoimmunity. Springer Semin Immunopathol 2: 215–228CrossRefGoogle Scholar
  146. 143.
    Alarcon-Segovia D (1975) Drug-induced systemic lupus erythematosus and related syndromes. Clin Rheum Dis 1: 573–582Google Scholar
  147. 144.
    Gleichmann E, Gleichmann H (1976) Graft-versus-host reaction: a pathogenetic principle for the development of drug allergy, autoimmunity, and malignant lymphoma in non-chimeric individuals. Hypothesis. Zeitschrift für Krebsforschung 85: 91–109Google Scholar
  148. 145.
    Gleichmann E, Issa P, Elven EHV, Lamers MC (1978) The chronic graft versus host reaction: a lupus like syndrome caused by abnormal T — B cell interaction. Clin Rheum Dis 4: 587–602Google Scholar
  149. 146.
    Kimura M, Andoh T, Kai K (1980) Failure to detect type-C virus p30-related antigen in systemic lupus erythematosus: false positive reaction due to protease activity. Arthritis Rheum 23: 111–113PubMedCrossRefGoogle Scholar
  150. 147.
    Kurata M, Katamine S, Fukuda T, Mine M, Ikari N, Kanazawa H, Matsunaga M, Eguchi K, Nagataki S (1985) Production of a monoclonal antibody to a membrane antigen of human T-cell leukemia virus (HTLV/ATLV)-infected cell lines from a systemic lupus erythematosus (SLE) patient: serologic analyses for HTLV infections in SLE patients. Clin Exp Immunol 62: 65–74PubMedGoogle Scholar
  151. 148.
    Panem S, Ordonez NG, Kirstein WH, Katz AI, Spargo BH (1976) C-type virus expression in systemic lupus erythematosus. N Engl J Med 295: 470–475PubMedCrossRefGoogle Scholar
  152. 149.
    Maeda S, Yonezawa K, Yachi A (1985) Serum antibody reacting with placental syncytiotrophoblast in sera of patients with autoimmune diseases — a possible relation to type C RNA retrovirus. Clin Exp Immunol 60: 645–553PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1987

Authors and Affiliations

  • W. Graninger
  • C. C. Zielinski
  • J. S. Smolen

There are no affiliations available

Personalised recommendations